GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (OCSE:BIOPOR) » Definitions » YoY Rev. per Sh. Growth

Bioporto AS (OCSE:BIOPOR) YoY Rev. per Sh. Growth : 0.00% (As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Bioporto AS YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Bioporto AS's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 0.00%.

Bioporto AS's Revenue per Share for the three months ended in Sep. 2024 was kr0.02.

Bioporto AS YoY Rev. per Sh. Growth Historical Data

The historical data trend for Bioporto AS's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioporto AS YoY Rev. per Sh. Growth Chart

Bioporto AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.64 -27.33 -20.18 4.60 -5.49

Bioporto AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.33 -41.38 4.17 4.35 -

Bioporto AS YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Bioporto AS's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.086-0.091)/ | 0.091 |
=-5.49 %

Bioporto AS's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(0.023-0.023)/ | 0.023 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioporto AS YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Bioporto AS's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioporto AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (OCSE:BIOPOR) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
TMO DHR XSWX:LONN A IQV IDXX MTD WAT SHSE:603259 ILMN NTRA LH ICLR DGX RVTY XPAR:BIM EXAS MEDP QGEN XPAR:ERF
Traded in Other Exchanges
2P4:Germany
Address
Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Website
https://www.bioporto.com
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Bioporto AS Headlines

No Headlines